ProSciento

Phase 2 Clinical Trials > Clinical Sites

ProSciento is full-service clinical research organization (CRO) focused on diabetes, obesity and NAFLD/NASH. ProSciento’s team of experts with clients throughout the U.S., Europe and Asia to support their metabolic drug and device candidates from IND/CTA and NDA/ANDA regulatory filing to final report publication and licensing support. www.prosciento.com

Contact

Abby Devine Director, Corporate Communications Phone: 858-663-6148
Yeonjoo Kang, PhD Director of Business Development Phone: (619) 240-8278
www.prosciento.com
855 3rd Avenue Suite 4400 Chula Vista, CA 91911